Stay up to date on the issues impacting the industry and be the first to hear about news and changes at Rael & Letson.
Interest in psychedelic-assisted therapy is rising, but coverage in multiemployer plans remains rare. Learn how sponsors can evaluate this evolving space—and why communication is key to improving access, safety, and awareness.
Read moreDrug rebates are meant to lower costs, but limited transparency and misaligned incentives raise questions. Learn how employers can evaluate PBM practices and ensure their plan delivers real value and long-term savings.
Read moreBefore replacing a wellness program or vendor, you might want to check your communications. Even the best programs can face low engagement when there is poor or confusing outreach or issues accessing services.
Read moreThere is a gap between mental health coverage and actual care received. Consider these strategies to provide access to effective, affordable, timely care.
Read moreRael & Letson surveys selected health insurers each year about the percentage increase in medical and prescription rates multiemployer plans may expect.
Read moreAs AI tools rapidly become part of healthcare benefits, it’s important for Trusts to know how AI might impact plans and participants.
Read moreChanging health plans requires careful review of financial, legal, operational, and participant impacts to ensure a smooth transition and fulfill trustee fiduciary duties.
Read moreLearn what the Actuarial Standards of Practice have to say about these controversial topics, and what they mean for a client’s retiree health valuation.
Read moreThe current administration is looking to make many popular drugs more accessible. Could these efforts impact your pharmacy benefit plan?
Read more